Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Feb 28, 2026 | (Q2)Nov 30, 2025 | (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1,341.30%138.24K | 13.44%-43.04K | 89.56%-1.75K | 56.26%-101.73K | 77.01%-24.15K | 89.57%-11.14K | -1,017.44%-49.72K | 36.11%-16.73K | -184.51%-232.56K | -1,448.01%-105.04K |
| Net income from continuing operations | 1,274.75%113.34K | 317.06%92.45K | 277.73%102.64K | 79.61%-154.99K | 96.18%-45K | -116.11%-9.65K | 81.89%-42.59K | -109.72%-57.75K | -377.56%-760.04K | -1,697.24%-1.18M |
| Operating gains losses | ---- | ---- | ---- | 95.52%-26.44K | ---- | ---- | ---- | ---- | ---589.49K | --3.9K |
| Depreciation and amortization | -18.75%52 | -19.12%55 | -18.31%58 | -18.52%264 | -18.67%61 | -18.99%64 | -18.07%68 | -18.39%71 | -18.59%324 | -18.48%75 |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --996.9K | ---- |
| Unrealized gains and losses of investment securities | -448.60%-145.75K | -775.26%-103.73K | -351.39%-116.65K | -57.44%66.53K | -75.55%31.34K | 70.21%-26.57K | -86.90%15.36K | 51,456.67%46.4K | 30,081.08%156.34K | 224,815.79%128.2K |
| Other non cashItems | ---- | ---- | ---- | 94.15%-1.9K | ---- | ---- | ---- | ---- | -1,004.69%-32.5K | ---- |
| Change In working capital | 582.00%170.6K | -41.07%-31.82K | 324.05%12.2K | 461.00%14.8K | 178.74%17.79K | 131.90%25.02K | -130.58%-22.55K | -123.53%-5.45K | -105.16%-4.1K | -129.85%-22.59K |
| -Change in receivables | -1,683.19%-51.98K | 95.85%-266 | -94.51%848 | 200.54%36K | 419.70%29.89K | 51.74%-2.92K | 57.72%-6.41K | 393.18%15.44K | -324.31%-35.81K | -1,740.00%-9.35K |
| -Change in prepaid assets | 106.15%509 | -247.30%-601 | -3.58%-1.56K | -5,149.70%-8.87K | -86.66%511 | -588.55%-8.28K | 107.16%408 | ---1.51K | -104.06%-169 | 383,200.00%3.83K |
| -Change in payables and accrued expense | 513.28%222.07K | -86.94%-30.95K | 166.68%12.92K | -138.68%-12.33K | 26.12%-12.61K | 148.89%36.21K | -117.50%-16.56K | -168.18%-19.37K | -46.26%31.88K | -122.73%-17.07K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1,341.30%138.24K | 13.44%-43.04K | 89.56%-1.75K | 56.26%-101.73K | 77.01%-24.15K | 89.57%-11.14K | -1,017.44%-49.72K | 36.11%-16.73K | -184.51%-232.56K | -1,448.01%-105.04K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -26,186.67%-394.3K | 0 | 0.00%-1.5K | -74.02%17.74K | 165.48%20.74K | 96.09%-1.5K | 0 | -101.09%-1.5K | 164.33%68.27K | 68.31%-31.67K |
| Net PPE purchase and sale | -26,186.67%-394.3K | --0 | 0.00%-1.5K | 464.30%17.74K | 165.48%20.74K | 96.62%-1.5K | --0 | -101.09%-1.5K | 95.41%-4.87K | 70.15%-31.67K |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --73.13K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -26,186.67%-394.3K | --0 | 0.00%-1.5K | -74.02%17.74K | 165.48%20.74K | 96.09%-1.5K | --0 | -101.09%-1.5K | 164.33%68.27K | 68.31%-31.67K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 300K | 0 | 116.67%50K | -155.56%-300K | 0 | 0 | 0 | -200.00%-300K | 440.00%540K | 225.00%325K |
| Net issuance payments of debt | --300K | --0 | 116.67%50K | -250.00%-300K | --0 | --0 | --0 | -200.00%-300K | 100.00%200K | 200.00%300K |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --340K | --25K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --300K | --0 | 116.67%50K | -155.56%-300K | --0 | --0 | --0 | -200.00%-300K | 440.00%540K | 225.00%325K |
| Net cash flow | ||||||||||
| Beginning cash position | -57.22%9.22K | -26.68%52.26K | -98.59%5.5K | 2,723.85%389.49K | -95.57%8.92K | -31.26%21.55K | 180.89%71.27K | 2,723.85%389.49K | -86.43%13.79K | 3,285.56%201.2K |
| Current changes in cash | 447.74%43.94K | 13.44%-43.04K | 114.69%46.75K | -202.21%-383.99K | -101.81%-3.41K | -107.44%-12.64K | -931.37%-49.72K | -2,848.30%-318.23K | 527.65%375.7K | 2,298.60%188.29K |
| End cash Position | 496.33%53.16K | -57.22%9.22K | -26.68%52.26K | -98.59%5.5K | -98.59%5.5K | -95.57%8.92K | -31.26%21.55K | 180.89%71.27K | 2,723.85%389.49K | 2,723.85%389.49K |
| Free cash from | -1,926.24%-256.06K | 13.44%-43.04K | 82.18%-3.25K | 75.71%-110.43K | 78.16%-29.85K | 91.64%-12.64K | 18.73%-49.72K | 82.73%-18.23K | -141.99%-454.58K | -48.36%-136.71K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.